相关实验视频
Updated: Jun 23, 2026

08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
临床实施和针对患者的质量保证解决方案,用于实时目标跟踪和Radixact同步中的动态交付
Christian D Trujillo-Bastidas1, Michael J Taylor2, Gloria M Díaz-Londoño3
1Clínica de Oncología Astorga, Departamento de Radioterapia/Universidad Nacional de Colombia - Sede Medellín, Facultad de Ciencias, Departamento de Física, Grupo de Investigación de Física Radiológica, Medellín, Colombia.
Journal of applied clinical medical physics
|October 3, 2024
概括
这项研究验证了Radixact与Synchrony系统的新质量保证协议,确保在接受高级放射治疗的癌症患者中准确的剂量输送和运动跟踪.
科学领域:
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
- 辐射疗法质量保证 辐射疗法质量保证
背景情况:
- 哥伦比亚的第一个Radixact与Synchrony系统需要一个质量保证 (QA) 协议,用于剂量输送和运动跟踪.
- 有限的临床试验数据和推的设备存在于同步评估.
研究的目的:
- 在临床条件下验证用于Synchrony功能的替代动态患者特定QA (PSQA) 设置.
- 为实施螺旋同步的新中心提供指导.
主要方法:
- 在CIRS动态平台上使用了Iba miniPhantomR,用于电影和阵列设置的信托标记.
- 使用二维马分析评估运动补偿 (M1S1) 和无运动补偿 (M1S0) 场景.
- 用同步模拟用于治疗前评估和验证患者运动痕迹.
主要成果:
- M1S0和M1S1的结果与之前的Synchrony功能研究一致.
- 在基于玛标准的各种运动范围中观察到剂量学差异.
- 有效的kV-剂量减去对于基于阵列的动态PSQA具有严格的马标准至关重要;没有检测到对EBT3膜的影响.
结论:
- 验证了两个动态PSQA配置用于临床集成.
- 评估了基于数组和基于电影的Synchrony方法的好处和局限性.
- 同步模拟和患者病例分类表可以帮助新用户实现同步.
相关概念视频
Pulse rhythm
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

